UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000004976
Receipt number R000005915
Scientific Title A Multicenter Phase II trial of TS-1/oxaliplatin (SOX) +bevacizumab in patients with unresectable advanced/metastatic colorectal cancer (HiSCO-02)
Date of disclosure of the study information 2011/03/01
Last modified on 2018/06/14 17:35:17

No. Disposal Last modified on Item of update
1 Insert 2011/01/28 22:37:15
2 Update 2011/04/21 17:23:11 Last name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Address
Address
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
3 Update 2011/04/21 17:23:59 Recruitment status
4 Update 2018/05/27 10:46:33 Key inclusion criteria
5 Update 2018/05/27 10:57:23 TEL
Email
Name of primary person or sponsor
Organization
Organization
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2018/05/27 11:04:42 Recruitment status
URL releasing protocol
Publication of results
URL related to results and publications
Results
7 Update 2018/06/14 17:35:17 UMIN ID1